This inventor holds 1 USPTO granted patent. Top assignee: Sugen Incorporated. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Jinrong Cui: Innovator in Kinase Inhibitors
Introduction
Jinrong Cui is a notable inventor based in Albany, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His work focuses on innovative compounds that have the potential to impact therapeutic strategies for various diseases.
Latest Patents
Jinrong Cui holds a patent for "3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors." This invention relates to specific indolinone compounds, their synthesis methods, and a combinatorial library of these compounds. The patent also outlines methods for modulating the function of protein kinases using these indolinone compounds, as well as approaches for treating diseases by influencing protein kinases and related signal transduction pathways. He has 1 patent to his name.
Career Highlights
Cui is associated with Sugen Incorporated, a company that focuses on developing innovative therapies. His work at Sugen has allowed him to explore the therapeutic potential of his inventions in a collaborative environment.
Collaborations
Some of his notable coworkers include Xiaoyuan Li and Peng Cho Tang. Their collaborative efforts contribute to the advancement of research and development in the field of kinase inhibitors.
Conclusion
Jinrong Cui's innovative work in the development of kinase inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of various diseases.